Cutler Group LP Intercept Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Jul 18, 2023	BUY	$9.17 - $19.29 $2,751 - $5,787	300 New	300 $0
Q4 2022 Feb 07, 2023	SELL	$11.61 - $16.11 $42,957 - $59,607	-3,700 Reduced 72.55%	1,400 $1,000
Q3 2022 Oct 25, 2022	SELL	$12.21 - $19.7 $20,757 - $33,490	-1,700 Reduced 25.0%	5,100 $5,000
Q2 2022 Aug 04, 2022	SELL	$11.23 - $19.59 $241,445 - $421,185	-21,500 Reduced 75.97%	6,800 $54,000
Q1 2022 Apr 14, 2022	BUY	$13.37 - $17.79 $377,034 - $501,678	28,200 Added 28200.0%	28,300 $66,000
Q2 2021 Jul 19, 2021	SELL	$15.46 - $24.5 $6,184 - $9,800	-400 Reduced 80.0%	100 $0
Q1 2021 Apr 26, 2021	BUY	$19.33 - $37.75 $3,865 - $7,550	200 Added 66.67%	500 $0
Q1 2020 May 07, 2020	SELL	$48.35 - $118.68 $352,955 - $866,364	-7,300 Reduced 96.05%	300 $11,000
Q4 2019 Feb 06, 2020	SELL	$57.36 - $124.1 $980,856 - $2.12 Million	-17,100 Reduced 69.23%	7,600 $4,000
Q3 2019 Oct 28, 2019	BUY	$58.69 - $80.46 $1.3 Million - $1.79 Million	22,200 Added 888.0%	24,700 $255,000
Q2 2019 Aug 09, 2019	SELL	$77.77 - $120.68 $653,268 - $1.01 Million	-8,400 Reduced 77.06%	2,500 $90,000
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $532,614 - $699,944	5,800 Added 113.73%	10,900 $164,000
Q4 2018 Feb 05, 2019	BUY	$85.79 - $126.46 $128,685 - $189,690	1,500 Added 41.67%	5,100 $237,000
Q3 2018 Nov 07, 2018	BUY	$88.49 - $127.55 $176,980 - $255,100	2,000 Added 125.0%	3,600 $108,000
Q2 2018 Aug 10, 2018	SELL	$60.0 - $85.67 $600,000 - $856,700	-10,000 Reduced 86.21%	1,600 $49,000
Q4 2017 Jan 17, 2018	SELL	$58.2 - $72.76 $721,680 - $902,224	-12,400 Reduced 51.67%	11,600 $329,000
Q3 2017 Oct 17, 2017	BUY	$57.01 - $118.75 $1.37 Million - $2.85 Million	24,000	24,000 $646,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account